Literature DB >> 22581473

A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice.

Déborah Heydet1, Lesley X Chen, Claire Z Larter, Chrystal Inglis, Michael A Silverman, Geoffrey C Farrell, Michel R Leroux.   

Abstract

Primary cilia are ubiquitous cellular antennae whose dysfunction collectively causes various disorders, including vision and hearing impairment, as well as renal, skeletal, and central nervous system anomalies. One ciliopathy, Alström syndrome, is closely related to Bardet-Biedl syndrome (BBS), sharing amongst other phenotypic features morbid obesity. As the cellular and molecular links between weight regulation and cilia are poorly understood, we used the obese mouse strain foz/foz, bearing a truncating mutation in the Alström syndrome protein (Alms1), to help elucidate why it develops hyperphagia, leading to early onset obesity and metabolic anomalies. Our in vivo studies reveal that Alms1 localizes at the base of cilia in hypothalamic neurons, which are implicated in the control of satiety. Alms1 is lost from this location in foz/foz mice, coinciding with a strong postnatal reduction (∼70%) in neurons displaying cilia marked with adenylyl cyclase 3 (AC3), a signaling protein implicated in obesity. Notably, the reduction in AC3-bearing cilia parallels the decrease in cilia containing two appetite-regulating proteins, Mchr1 and Sstr3, as well as another established Arl13b ciliary marker, consistent with progressive loss of cilia during development. Together, our results suggest that Alms1 maintains the function of neuronal cilia implicated in weight regulation by influencing the maintenance and/or stability of the organelle. Given that Mchr1 and Sstr3 localization to remaining cilia is maintained in foz/foz animals but known to be lost from BBS knockout mice, our findings suggest different molecular etiologies for the satiety defects associated with the Alström syndrome and BBS ciliopathies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581473     DOI: 10.1002/dneu.22031

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  24 in total

Review 1.  Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity.

Authors:  Francesca Dassie; Francesca Favaretto; Silvia Bettini; Matteo Parolin; Marina Valenti; Felix Reschke; Thomas Danne; Roberto Vettor; Gabriella Milan; Pietro Maffei
Journal:  Endocrine       Date:  2021-02-10       Impact factor: 3.633

Review 2.  Cilia and Obesity.

Authors:  Christian Vaisse; Jeremy F Reiter; Nicolas F Berbari
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-07-05       Impact factor: 10.005

Review 3.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

4.  Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.

Authors:  George N Ioannou; Derrick M Van Rooyen; Christopher Savard; W Geoffrey Haigh; Matthew M Yeh; Narci C Teoh; Geoffrey C Farrell
Journal:  J Lipid Res       Date:  2014-12-17       Impact factor: 5.922

Review 5.  Metabolic regulation and energy homeostasis through the primary Cilium.

Authors:  Edwin C Oh; Shivakumar Vasanth; Nicholas Katsanis
Journal:  Cell Metab       Date:  2014-12-24       Impact factor: 27.287

6.  Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.

Authors:  Fahrettin Haczeyni; Laurence Poekes; Hans Wang; Auvro R Mridha; Vanessa Barn; W Geoffrey Haigh; George N Ioannou; Matthew M Yeh; Isabelle A Leclercq; Narcissus C Teoh; Geoffrey C Farrell
Journal:  Obesity (Silver Spring)       Date:  2016-11-02       Impact factor: 5.002

7.  Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alström syndrome.

Authors:  Amine Chakroun; Mariem Ben Said; Amine Ennouri; Imen Achour; Mouna Mnif; Mohamed Abid; Abdelmonem Ghorbel; Jan D Marshall; Jürgen K Naggert; Saber Masmoudi
Journal:  Eur J Med Genet       Date:  2016-08-12       Impact factor: 2.708

8.  Pituitary morphovolumetric changes in Alström syndrome.

Authors:  Valentina Citton; Pietro Maffei; Jan D Marshall; Alessandro Baglione; Gayle B Collin; Gabriella Milan; Roberto Vettor; Jürgen K Naggert; Renzo Manara
Journal:  J Neuroradiol       Date:  2015-12-17       Impact factor: 3.447

9.  Comprehensive Endocrine-Metabolic Evaluation of Patients With Alström Syndrome Compared With BMI-Matched Controls.

Authors:  Joan C Han; Daniela P Reyes-Capo; Chia-Ying Liu; James C Reynolds; Evrim Turkbey; Ismail Baris Turkbey; Joy Bryant; Jan D Marshall; Jürgen K Naggert; William A Gahl; Jack A Yanovski; Meral Gunay-Aygun
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

Review 10.  Meckel-Gruber syndrome and the role of primary cilia in kidney, skeleton, and central nervous system development.

Authors:  Amy R Barker; Rhys Thomas; Helen R Dawe
Journal:  Organogenesis       Date:  2013-12-09       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.